The present invention relates to devices and instrumentalities for inserting an intramedullary nail within the medullary canal of a longbone, such as a femur, along a retrograde insertion trajectory.
Femoral fractures are often treated with screws or other fixation devices inserted into or through a bone to stabilize fractured portions thereof once they have been brought into corrective alignment. Femoral trochanteric bone fixation treatments comprise the insertion of an intramedullary nail into the medullary cavity of the femur and a subsequent insertion of a bone fixation screw into a condylar portion of the femur at an angle relative to the intramedullary nail (i.e., along an axis of the femoral neck and center of the femoral head).
Femoral intramedullary nails are typically designed for either an antegrade or retrograde insertion trajectory into the medullary canal. Antegrade insertion trajectories extend from the anatomical proximal end of the femur (i.e., at the hip joint), such as from the tip or slightly lateral to the tip of the greater trochanter, and into the medullary canal toward the anatomical distal end of the femur along the anatomical axis of the femur. Retrograde insertion trajectories extend from the anatomical distal end of the femur (i.e., at the knee joint) toward the anatomical proximal end of the femur and are effectively the opposite of antegrade insertion trajectories.
As used herein, the term “retrograde intramedullary nail” refers to an intramedullary nail designed for retrograde insertion into the medullary canal. Retrograde intramedullary nails are known to provide advantageous fixation to the distal portions of the femur (e.g., the distal condylar and intercondylar regions), such as for treating distal femur fractures. For example, retrograde intramedullary nails allow for easier targeting and insertion of locking screws within locking holes at the trailing end of the nail, which resides within the distal femur. The targeting and insertion of locking nails screws at the trailing end of the nail is simplified by the fact that the trailing end can be directly engaged with instrumentation, such as an insertion handle and/or an aiming arm having aiming elements for targeting the locking holes near the trailing end of the nail. Targeting the locking holes at the trailing end of the retrograde nail (at the distal femur) is further simplified by the fact that the trailing end experiences less deflection and/or deformation than the leading end (at the proximal femur), particularly as the nail length increases. Targeting locking holes at the leading end of a retrograde intramedullary nail, however, is more challenging due to factors such as nail deflection resulting from stress and strain, particularly as the length of the nail increases, and also due to manufacturing tolerances in the nail bend shape. Stress and strain at the leading end of the nail can be exacerbated while “locking” the leading end (i.e., targeting and inserting fixation members, such as bone screws, through locking holes at the leading end).
According to an embodiment of the present disclosure, a retrograde intramedullary nail for retrograde insertion in the medullary canal of a femur includes a body that is elongate and defines a leading end and a trailing end spaced from each other at a length sufficient to extend from an intercondylar region at least to a subtrochanteric region of the femur. The body further defines a leading portion that extends to the leading end. The leading portion defines at least one locking hole configured to receive a fixation member. The at least one locking hole defines a central hole axis that is configured to extend through the neck of the femur and intersect the head of the femur.
According to another embodiment of the present disclosure, a system for femoral fixation includes an intramedullary nail having a body that is elongate and defines a leading end and a trailing end spaced from each other at a length sufficient to extend from an intercondylar region of the femur at least to a subtrochanteric region of the femur. A leading portion of the body extends to the leading end and defines at least one locking hole configured to receive at least one fixation member for affixing the leading portion to the femur. The leading portion also defines at least one relief formation configured to reduce stress concentrations in the leading portion. The system includes an aiming assembly configured to connect to the leading portion and insert at least one fixation member through the at least one locking hole.
According to an additional embodiment of the present disclosure, a method includes advancing an intramedullary nail within a medullary canal of a femur along a retrograde insertion trajectory, thereby positioning a trailing end of the intramedullary nail within an intercondylar region of the femur while concurrently positioning a leading end of the intramedullary nail within or anatomically proximal to a subtrochanteric region of the femur and aligning at least one locking hole defined by the nail with one or more regions of the femur that include the subtrochanteric region, a transtrochanteric region, a trochanteric region, and an intracapsular region.
The foregoing summary, as well as the following detailed description of illustrative embodiments of the present application, will be better understood when read in conjunction with the appended drawings. For the purposes of illustrating the structures of the present application, there is shown in the drawings illustrative embodiments. It should be understood, however, that the application is not limited to the precise arrangements and instrumentalities shown. In the drawings:
The present disclosure can be understood more readily by reference to the following detailed description taken in connection with the accompanying figures and examples, which form a part of this disclosure. It is to be understood that this disclosure is not limited to the specific devices, methods, applications, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the scope of the present disclosure. Also, as used in the specification including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise.
The term “plurality”, as used herein, means more than one. When a range of values is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. All ranges are inclusive and combinable.
The terms “approximately” and “substantially”, as used herein with respect to dimensions, angles, and other geometries, take into account manufacturing tolerances. Further, the terms “approximately” and “substantially” can include 10% greater than or less than the stated dimension or angle. Further, the terms “approximately” and “substantially” can equally apply to the specific value stated.
As used herein with reference to an intramedullary nail or a component thereof, the term “trailing end” refers to the end nearest instrumentation for inserting the nail or component thereof. Similarly, the term “leading end”, as used herein with reference to an intramedullary nail or a component thereof, refers to the end that first engages tissue (e.g., bone tissue) as the nail or component thereof is inserted into the femur.
The retrograde intramedullary nails of the present disclosure have features that allow the leading end of the nail to treat factures at proximal portions of the femur, such as for reconstructing subtrochanteric, transtrochanteric, trochanteric, intertrochanteric, and/or femoral neck fractures, in addition to shaft fractures and distal femoral fractures, by way of non-limiting examples. Furthermore, the retrograde intramedullary nails of the present disclosure can allow for prophylactic (i.e., preventative) fixation and support for proximal portions of the femur, such as at the femoral neck. Such prophylactic fixation can be particularly beneficial for higher risk populations, such as osteoporotic and/or obese patients, to reduce the risk of femoral neck fractures.
The retrograde intramedullary nails disclosed herein address technical challenges relating to providing retrograde nails at sufficient dimensions (i.e., lengths and widths/diameters) that can allow fixation at proximal regions of the femur from a retrograde insertion trajectory, including such challenges involving stress concentrations along the leading portion of the nail. For example, the retrograde intramedullary nails disclosed herein include features that reduce stress concentrations at the leading portion of the nail, allowing these retrograde intramedullary nails to be indicated for fractures in the subtrochanteric region and regions anatomically proximally beyond.
Additionally, the following disclosure includes features that facilitate targeting and locking the leading portion of the nail, which features address challenges relating to deflection of the leading portion during insertion within the medullary canal. Also disclosed herein is instrumentation, including an aiming assembly, for targeting and locking the leading portion of the nail.
Referring now to
For purposes of the following disclosure, reference will be made to various anatomical regions of the femur 202, including a proximal region 208, a distal region 210, and a shaft region 212 that extends between the proximal and distal regions 208, 210. It should be appreciated that the proximal region 208 is also referred to herein as the “proximal femur” 208; the distal region 210 is also referred to herein as the “distal femur”; and the shaft region 212 is also referred to herein as the “shaft” 212.
The proximal femur 208 encompasses a plurality of sub-regions, including, for example:
Referring now to
Referring now to
The body 4 extends along a central nail axis X, which is preferably curved at least along portions thereof to correspond to the anatomical axis 200 of the femur 202 (see
The nail body 4 can be constructed of a biocompatible material selected from a group comprising: metal, such as titanium, titanium alloys (e.g., titanium-aluminum-vanadium (TAV) alloys such as Ti-6Al-4V, titanium-aluminum-niobium (TAN) alloys such as Ti-6Al-7Nb, and titanium-molybdenum alloys (Ti—Mo) or any other molybdenum metal alloy, and nickel-titanium alloys, such as nitinol), stainless steel, and cobalt base alloys (e.g., cobalt-chrome alloys); composite materials; polymeric materials; ceramic materials; and/or resorbable materials, including resorbable versions of the foregoing material categories (metals, composites, polymers, ceramics). The material of the nail body 4 is preferably radiopaque or the nail body 4 can carry radiopaque markers for observation under fluoroscopy to assist the physician during the implantation procedure, including for targeting locking holes of the nail body 4, as described in more detail below. The nail body 4 is preferably monolithic. However, in other embodiment, the body 4 can include two or more separate parts coupled together. By way of a non-limiting example of such a non-monolithic nail body 4, the head 4a and main shaft portion 4c can be monolithic with each other and can be constructed of a TAV alloy, and the leading portion 4b can be constructed of a Ti—Mo alloy. Other non-monolithic combinations are also within the scope of the present disclosure.
Referring now to
The exterior surface 12 can also include one or more secondary surface portions or formations that deviate from the primary surface portion 12a. For example, the body 4 can define a secondary formation in the form of a plurality of longitudinal grooves 12b, which can extend along the main shaft portion 4c and optionally along portions of the head 4a and/or the leading portion 4b. The grooves 12b can be configured to reduce stiffness of the nail 2 so as to enhance bone healing, guide insertion of the nail 2 along the medullary canal, distribute stresses (such as by reducing stress concentrations) within the nail body 4, strengthen the nail 2, and/or reduce the overall weight of the nail 2, by way of non-limiting examples. Other formation geometries that deviate from the primary surface portion 12a are also within the scope of the present disclosure.
The head 4a is configured to attach to instrumentation for inserting the nail 2 into the medullary canal. For example, the trailing end 6 can include a mounting formation 14 for mounting to a complementary receiving formation of an instrument, such as an insertion handle. The head 4a can optionally define a head width W2 that is greater than the shaft width W1. The head 4a can also define a taper or “neck” 16 along which the width transitions from the head width W2 to the shaft width W1.
The head 4a also defines one or more trailing locking holes 18 extending through the body 4 along one or more various directions that are offset from the longitudinal direction L. These directions can be perpendicular or oblique to the longitudinal direction L. In the illustrated embodiment, the head 4a defines four (4) trailing locking holes 18, although fewer or more than four (4) holes are also within the scope of the present disclosure. The trailing locking holes 18 are each configured to receive a fixation member, such as a bone screw or a spiral blade, that extends through the respective hole 18 and affixes the head 4a of the nail 2 to the distal femur 210 (see
The dimensions of the nail 2, such as the length L1 and the widths W1, W2 of the head 4a and the main shaft portion 4c can vary depending on a number of factors, including factors dependent on patient anatomy, such as the dimensions of the femur 202 to receive the nail 2 and the type of retrograde fixation desired (e.g., reconstruction and/or prophylactic). The length L1 can be in a range of about 120 mm to about 500 mm. The shaft width W1 of the main shaft portion 4c can be in a range of about 8 mm to about 16 mm. The width W1 of the head 4a can be in a range of about 8 mm to about 18 mm.
Referring now to
The leading portion 4b can also define one or more coupling features, such as coupling apertures 30, for coupling an aiming assembly to the leading portion 4b for targeting the locking hole(s) 26. The coupling apertures 30 can extend through the nail body 4, between the lateral and medial sides 20, 22 thereof, along respective aperture axes 32 that are preferably parallel with each other and preferably parallel with the locking holes axes 28. As shown, the leading portion 4b can define two (2) coupling apertures 30 positioned astride the locking holes 26 along the longitudinal direction L, although other configurations are within the scope of the present disclosure. It should also be appreciated that a single coupling aperture 30 or more than two (2) coupling apertures 30 can be employed. The coupling apertures 30 will be discussed in more detail below.
The locking holes 26 are spaced from each other at a hole spacing distance L2, which can be measured from the respective locking hole axes 28 along the longitudinal direction L. As shown in
The hole spacing distance L2, the locking hole diameters D1, and the orientation of the locking hole axes 28 can be selected so that each of the corresponding fixation members 10 can extend through the locking holes 26 and through the femoral neck 216, as shown in
It should be appreciated, however, that the locking hole(s) of the leading portion 4b can have various configurations and can be adapted for various treatments. For example, although the illustrated locking holes 26 have a circular cross-sectional shape (in a reference plane orthogonal to the locking hole axis 28), other locking hole 26 shapes are within the scope of the present disclosure. For example, one or more of the locking holes 26 can be configured for use with spiral blade type fixation members 10. In other embodiments, one or more of the locking holes 26 can have an oblong cross-sectional shape configured for allowing the associated fixation member 10 to be inserted therethrough at variable angles. Such variable-angle locking member 10 insertion can be particularly beneficial for reconstructing the proximal femur 208. Other variable-angle locking hole 26 configurations are described below. In further embodiments, one or more of the locking holes 26 can be a partial or “semi-hole” at the edge of the leading portion 4b of the nail body 4.
In additional embodiments, one of the locking holes 26 can be adapted to receive a multi-channel fixation barrel that extends through the leading portion 4b and toward the femoral head. The fixation barrel can define a primary channel and a secondary channel, which can be angularly offset from each other. The primary channel is configured to receive a primary fixation member 10, such as a bone screw or bolt, that extends through the barrel and the femoral neck 216 and into the femoral head 214. The secondary channel is configured to receive an additional fixation member, such as an anti-rotation screw that extends through the femoral neck and into the femoral head 214 at an acute angle relative to the primary fixation member 10. In this manner, the secondary fixation member can be configured to prevent subsequent rotation of the femoral head 214 about the axis of the primary fixation member 10.
With continued reference to
Referring now to
In other embodiments, the leading portion 4b of the nail 2 can be configured such that the leading width W3 differs than the shaft width W1. For example, the leading width W3 can be less than the shaft width W1. In such embodiment, the leading width W3 can taper or otherwise diminish from the shaft width W1 toward the leading end 8 of the nail 2. In yet other embodiment, the leading width W3 can be greater than the shaft width W1. In such embodiments, the nail body 4 can taper outwardly at a transition from the main shaft portion 4c to the leading portion 4b, such that the leading width W3 is greater than the shaft width W1 (at least as measured leading into the transition) by a distance in a range from about 0.01 mm to about 1.50 mm. This outwardly leading taper can terminate at a location trailingly spaced from the trailing-most hole 26, 30 in the leading portion 4b, and is preferably gradual for minimizing stress concentrations at or adjacent the taper.
In further embodiments, as shown in
In additional embodiments, the leading portion 4b can be non-monolithic with the main shaft portion 4c. In such embodiments, the leading portion 4b can be configured to rotate relative to the main shaft portion 4c. For example, the leading portion 4b can be configured to rotate about the central shaft axis X under control of instrumentation, such as a tool insertable within the nail body 4 through the cannulation. In this manner, the rotational position of the leading portion 4b can be rotated to align the locking holes 26 with femoral anatomy as needed.
In further embodiments, the nail body 4 can be configured such that the leading portion 4b flexes directly into the femoral neck 216. In such embodiments, the relief formations can be particularly configured to allow the leading portion 4b to undergo such flexion while maintaining sufficient rigidity to support the femoral neck 216.
Referring now to
The aiming assembly 102 can include an aiming guide, such as a guide block 108, that is configured to translate along the guide wires 104 toward the intramedullary nail 2. For example, the guide block 108 can define one or more guide holes 110 configured to align with the coupling holes 30 of the nail 2. The guide holes 110 are each configured to receive a corresponding guide wire 104 therein. For example, the guide holes 110 can be configured for sliding engagement with a corresponding guide sleeve 106 therein, which is, in turn, configured for sliding engagement with a corresponding guide wire 104 therein. In this manner, the aiming block 108 can translate along the guide wires 104 toward the intramedullary nail 2 for targeting the locking holes 26 in the leading portion 4b of the nail body 4. The aiming block 108 preferably includes a handle 115 allowing the physician to manipulate the aiming block 108 as needed. One or more locking members, such as locking pins 112, can extend through the guide block 108 and into communication with the guide holes 110, such that the physician can manipulate the locking pins 112 to affix the position of the guide block 108 with respect to the guide sleeves 106 and guide wires 104. For example, the locking pins 112 can each define a cam surface that engages and disengages the guide sleeves 106 as the locking pins 112 are rotated back and forth, such as about ninety degree (90°) quarter turns about central axes 114 of the locking pins 112.
The guide block 108 defines at least one aiming channel 120 for targeting the at least one locking hole 26 of the leading portion 4b of the nail body 4. In the illustrated embodiment, the guide block 108 defines two aiming channels 120 that are configured to target two locking holes 26 of the leading portion 4b. Accordingly, as shown in
The aiming channels 120 can each be configured to receive an insertion device 130 for inserting the fixation members 10 in the locking holes 26. The insertion device 130 can be a multi-part device, such as a three-part trocar combination that includes an outer protection sleeve 132, a drill sleeve 134 insertable through the protection sleeve, and a trocar 136 insertable through the drill sleeve incising soft tissue preferably along the locking hole axis 28 toward the locking hole 26. Operation of the insertion device 130 will be described in more detail below. An additional locking member, such as a locking pin 113, can extend through the guide block 108 and into communication with the aiming channels 120, such that the physician can manipulate the locking pin 113 to affix the position of the outer protection sleeve 132 with respect to the guide block 108.
It should be appreciated that the aiming assembly 102 described above is provided as a non-limiting example of an aiming mechanism for targeting the locking holes 26 at the leading portion 4b. Other types of aiming mechanisms are within the scope of the present disclosure. For example, the nail 2 can be connectable to a swiveling-type aiming arm sleeve, which can swivel about a pivot joint for targeting locking holes 26 that extend along angularly offset axes 28.
Additionally or alternatively, the nail 2 can be connectable to an aiming arm having an adjustment mechanism for providing precise adjustment of the position of its aiming channels along the longitudinal direction L. Such an aiming arm can also be configured to allow controlled deflection along the transverse direction T (i.e., the anterior-posterior direction). In this manner, the aiming arm can be manipulated for adjustable targeting along the longitudinal and transverse direction L, T.
Referring now to
An additional step includes locating 304 the entry point 201 of the retrograde insertion trajectory, such as an entry point 201 at the top of the intercondylar notch 222, as described above. The physician can then perform a step of inserting 306 a guide member, such as a guide wire, such as a k-wire, into the medullary canal through the entry point 201. With the guide member inserted, the physician can perform a step of opening 308 the medullary canal by advancing a canal-opening device, such as a drill bit and/or an awl, along the guide wire and through the entry point 201 and into the medullary canal. If needed after the opening step 308 (and the canal-opening device has been removed), the physician can optionally perform a canal-expanding or “reaming” step 310 by advancing a reamer along the guide wire and reaming bone tissue to expand the medullary canal in preparation for receiving the nail 2.
After the nail 2 has been selected and the medullary canal has been opened (and optionally reamed), the physician can perform a mounting step 312, whereby the nail 2 is mounted to an insertion handle and is further coupled to the guide wire (or a reaming rod if the optional reaming step 310 was performed). For example, the nail 2 can be assembled over or along the guide wire (or reaming rod). After the mounting step 312, the physician can manipulate the insertion handle for advancing 314 the nail 2 along the guide wire and into the medullary canal. The physician can use the insertion handle to manually insert 316 the nail 2 into the medullary canal as far as practicable by hand. If necessary, the physician can employ an impaction hammer for impacting 318 the insertion handle (such as by delivering hammer blows) to further insert the nail 2 to the final desired longitudinal position within the medullary canal. During the insertion process, the physician can monitor 320 the nail 2 position using fluoroscopy to ensure proper alignment and longitudinal positioning. For example, the physician can use fluoroscopy to determine when the locking holes 26 at the leading portion 4b of the nail body 4 are aligned with the femoral neck 216.
When the physician has determined that the nail 2 is inserted at the desired longitudinal position within the medullary canal, the physician can commence proximal locking 400, i.e., locking the leading portion 4b of the nail body 4 to the proximal femur 208, which will be described in more detail below. After proximal locking 400 is complete, the physician can begin distal locking 322, i.e, locking the trailing portion 4a of the nail 2 to the distal femur 210.
Referring now to
It should be appreciated that, after the first guide wire 104 has been inserted through the first coupling aperture 30 and the first guide sleeve 106 has been advanced along the first guide wire 104, the physician can alternatively couple the guide block 108 to the first guide sleeve 106 and first guide wire 104 before targeting the second guide wire 104 through the second coupling aperture 30. In this manner, the second guide hole 110 of the guide block 108 can provide guided targeting of the second coupling aperture 30. It should be appreciated that the flexion of the leading portion 4b of the nail body 4 (such as during nail 2 insertion in the medullary canal) can potentially reorient one or both of the locking hole axes 28 to a minor extent. Additionally, the first guide wire 104 can also potentially deflect the leading portion 4b as the first guide wire 104 advances through the first coupling aperture 30. Accordingly, during this alternative process for targeting the second coupling aperture 30, the physician can slide the guide block 108 (and the second guide sleeve 106) along the first guide wire 104 toward or away from the nail 2 as needed to reduce or increase the flexibility of the leading portion of the second guide wire 104.
The physician can then perform a step of locating 412 the guide block 108 at a desired targeting distance with respect to the nail 2 by advancing the guide block 108 along the guide sleeves 106 and guide wires 104 toward the nail 2 until the guide block 108 is located at the desired targeting distance, such as when a tip of the outer protection sleeve 132 of the insertion device 130 (disposed in one of the aiming channels 120) contacts the patient's skin or exposed soft tissue. With the guide block 108 located at the desired targeting distance, the physician can affix 414 the guide block 108 to the guide wires 104 and guide sleeves 106 by manipulating the locking pins 112 to their locked positions.
With the guide block 108 affixed at the desired targeting position with respect to the nail 2, the physician can employ the insertion device 130 through the aiming channels 120 of the guide block 108 for inserting 416 the fixation members 10 through the locking holes 26. For example, the physician can advance the trocar 136 through the drill sleeve 134 disposed in the outer protection sleeve 132 so that a leading cutting tip of the trocar 136 makes a stab incision through soft tissue and preferably to the outer surface of the near cortex along an incision path that is substantially aligned with the locking hole axis 28. After the incision is made, the trocar 136 is withdrawn from the drill sleeve 134 and the drill bit 138 is advanced through the drill sleeve 134 for pre-drilling an insertion channel through the near cortex and optionally for extending through the locking hole 26 and pre-drilling an extension of the insertion channel into bone tissue on the far side of the locking hole 26. After the pre-drilling is completed, the drill bit 138 can be withdrawn from the drill sleeve 134, and the drill sleeve 134 can be withdrawn. A driving tool 140 carrying the fixation member 10 at the leading end of the driving tool 140 can then be inserted through the outer protection sleeve 132. The driving tool 140 can advance the fixation member 10 through the outer protection sleeve 132 and, in turn, through the pre-drilled channel in the near cortex, through the locking hole 26, and through the femoral neck 216 until the fixation member 10 is fully seated with respect to the locking hole 26. At this fully seated position, the leading end of the fixation member 10 is preferably purchased within cortical bone of the femoral head 214. After the first fixation member 10 is inserted through the first targeted locking hole 26, the insertion device 130 can be withdrawn from the respective aiming channel 120 and inserted within the second aiming channel 120 for inserting a second fixation member 10 in the second targeted locking hole 26 in like manner. The physician can manipulate the additional locking pin 113 as needed to lock and unlock the insertion device within the first and second aiming channels 120.
Referring again to
It should be appreciated that the example method described above can also be adapted for treating femoral fractures (e.g., femoral reconstruction), including fractures at any and each of the distal femur 210, shaft 212, and proximal femur 208, in addition or alternative to prophylactic strengthening and support of the femoral neck. For example, to treat femoral fractures, the physician can perform additional, preliminary steps that can include: identifying the fracture site(s); reducing the fracture(s); and identifying one or more desired fixation members (e.g., bone screws and/or spiral blades) and associated approaches for fixating the fractured portion(s) of the femur. The step of selecting 302 the appropriate intramedullary nail 2 can include selecting a nail 2 having one or more locking holes respectively sized for such fixation member(s) and aligned with such approach(es).
It should be also appreciated that the foregoing methods are provided as examples, and that the physician can elect to adjust the sequence of various steps, omit one or more of the steps, and/or perform one or more additional steps, as needed.
Referring now to
The hole threads 33 are configured to threadedly engage (i.e., intermesh with) external threads 41 defined on the head 43 of the fixation member 10 (which threads 41 can also be referred to as “head threads” 41) as the head 43 advances within the VA locking hole 26a at either a nominal orientation (i.e., the central axis 15 of the fixation member 10 is colinear with the central hole axis 28a) or at an angulation within a predetermined angulation range. The head 43 of the fixation member 10 can be configured for VA insertion and locking within the VA locking hole 26a. For example, the head 43 can have curved, convex profile that allows the head threads 41 to threadedly engage the hole threads 33 at both a nominal orientation and at angulation. Furthermore, head 43 and the interior surface 27 can be cooperatively configured such that hole threads 33 and/or the head threads 41 deform as the head 43 advances within the VA locking hole 26a, thereby locking the position of the fixation member 10 with respect to the nail body 4. The nail body 4 also preferably defines at least one lead-in surface 34 and at least one undercut surface 36, that extend respectively from the outer surface of the nail body to the interior surface 27. The lead-in and undercut surfaces 34, 36 provide space for the head 43 and shaft of the fixation member 10 at angulated positions.
The VA locking holes 26a of the present embodiment allow the physician to select an advantageous angulation for the fixation member 10 through the hole 26a, which can be beneficial for inserting the fixation member 10 into a fractured portion of the proximal femur 208. Angulated insertion also allows the fixation members 10 to extend through the VA locking holes 26a and favorably through the femoral neck and into the femoral head even when the leading portion 4b of the nail 2 is slightly off its intended position and/or orientation in the medullary canal.
It should be appreciated that the VA locking holes 26a can have a circular hole profile, as viewed in a reference plane orthogonal to the central hole axis 28a. Alternatively, the VA locking holes 26a can have other hole profile shapes, such as a polygonal shape, such as a trigon shape that includes three (3) columns (that form the sides of the trigon) and three (3) recesses (that form the corners of the trigon) spaced between the columns. The polygonal and trigon holes can be configured as more fully described in U.S. Patent Publication No. 2021/0015526A1, published Jan. 21, 2021, entitled “DEFORMABLE THREADED LOCKING STRUCTURES, AND RELATED SYSTEMS AND METHODS,” the entire disclosure of which is incorporated by reference herein.
It should be appreciated that although the features disclosed above have been described with reference to retrograde insertion into a femur, the features of the intramedullary nail and related instrumentation described herein can also be employed for use with other longbones, including the humerus, radius, ulna, tibia, and fibula.
Although the disclosure has been described in detail, it should be understood that various changes, substitutions, and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. For example, features of the various embodiments described herein can be incorporated into one or more and up to all of the other embodiments described herein. Moreover, the scope of the present disclosure is not intended to be limited to the particular embodiments described in the specification. As one of ordinary skill in the art will readily appreciate from that processes, machines, manufacture, composition of matter, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present disclosure.
Number | Name | Date | Kind |
---|---|---|---|
3433220 | Zickel | Mar 1969 | A |
4475545 | Ender | Oct 1984 | A |
4622959 | Marcus | Nov 1986 | A |
4784124 | Kaltenbrunner | Nov 1988 | A |
4827917 | Brumfield | May 1989 | A |
4846162 | Moehring | Jul 1989 | A |
5034013 | Kyle et al. | Jul 1991 | A |
5035697 | Frigg | Jul 1991 | A |
5041115 | Frigg et al. | Aug 1991 | A |
5167663 | Brumfield | Dec 1992 | A |
5312406 | Brumfield | May 1994 | A |
5549610 | Russell et al. | Aug 1996 | A |
5573536 | Grosse et al. | Nov 1996 | A |
5620445 | Brosnahan et al. | Apr 1997 | A |
5697930 | Itoman et al. | Dec 1997 | A |
5779705 | Matthews | Jul 1998 | A |
5855579 | James et al. | Jan 1999 | A |
5935127 | Border | Aug 1999 | A |
6010506 | Gosney et al. | Jan 2000 | A |
6120504 | Brumback et al. | Sep 2000 | A |
6123708 | Kilpela et al. | Sep 2000 | A |
6126661 | Faccioli et al. | Oct 2000 | A |
6210414 | Lin | Apr 2001 | B1 |
6214013 | Lambrecht et al. | Apr 2001 | B1 |
6221074 | Cole et al. | Apr 2001 | B1 |
6228086 | Wahl et al. | May 2001 | B1 |
6270499 | Leu | Aug 2001 | B1 |
6299648 | Doubler et al. | Oct 2001 | B1 |
6402753 | Cole et al. | Jun 2002 | B1 |
6406477 | Fujiwara | Jun 2002 | B1 |
6443954 | Bramlet et al. | Sep 2002 | B1 |
6461360 | Adam | Oct 2002 | B1 |
6524313 | Fassier et al. | Feb 2003 | B1 |
6855146 | Frigg et al. | Feb 2005 | B2 |
6932818 | Behrens | Aug 2005 | B2 |
7018380 | Cole | Mar 2006 | B2 |
7041104 | Cole et al. | May 2006 | B1 |
7455673 | Gotfried | Nov 2008 | B2 |
7670340 | Brivio et al. | Mar 2010 | B2 |
7763023 | Gotfried | Jul 2010 | B2 |
7776038 | Prien | Aug 2010 | B2 |
7842036 | Phillips | Nov 2010 | B2 |
7867231 | Cole | Jan 2011 | B2 |
7914532 | Shaver et al. | Mar 2011 | B2 |
D638125 | Velikov | May 2011 | S |
D638126 | Velikov | May 2011 | S |
7947043 | Mutchler | May 2011 | B2 |
8137348 | Gotfried | Mar 2012 | B2 |
8157803 | Zirkle, Jr. et al. | Apr 2012 | B1 |
8257361 | Ritchey et al. | Sep 2012 | B2 |
8317788 | Kaup | Nov 2012 | B2 |
8353910 | Dell'Oca | Jan 2013 | B2 |
8394103 | O'Reilly et al. | Mar 2013 | B2 |
8409205 | Yang et al. | Apr 2013 | B2 |
8449544 | Grusin | May 2013 | B2 |
8540714 | Gordon et al. | Sep 2013 | B2 |
D693470 | Fagan | Nov 2013 | S |
8632543 | Metzinger et al. | Jan 2014 | B2 |
8652136 | Yang | Feb 2014 | B2 |
8668695 | Schwammberger et al. | Mar 2014 | B2 |
8679121 | Czartoski et al. | Mar 2014 | B2 |
8734448 | Thakkar | May 2014 | B2 |
8758345 | Sidebotham | Jun 2014 | B2 |
8790343 | McClellan et al. | Jul 2014 | B2 |
8834469 | Watanabe et al. | Sep 2014 | B2 |
8906023 | Matityahu et al. | Dec 2014 | B2 |
9011444 | Primiano et al. | Apr 2015 | B2 |
9044283 | Simon | Jun 2015 | B2 |
9072552 | Simon et al. | Jul 2015 | B2 |
9220544 | Matityahu et al. | Dec 2015 | B2 |
9301767 | Ritchey et al. | Apr 2016 | B2 |
9308031 | Elghazaly et al. | Apr 2016 | B2 |
9320551 | Frank et al. | Apr 2016 | B2 |
9333018 | Russell et al. | May 2016 | B2 |
9358049 | Simon et al. | Jun 2016 | B2 |
9408645 | Graca et al. | Aug 2016 | B2 |
9427266 | Kmiec, Jr. | Aug 2016 | B2 |
9433449 | Vega et al. | Sep 2016 | B2 |
9439695 | Wolter | Sep 2016 | B2 |
9775661 | Rabiner et al. | Oct 2017 | B2 |
RE47149 | Primiano et al. | Dec 2018 | E |
20060095039 | Mutchler | May 2006 | A1 |
20060106389 | Reber | May 2006 | A1 |
20070276385 | Schlienger et al. | Nov 2007 | A1 |
20070288017 | Kaup | Dec 2007 | A1 |
20080009873 | Yacoubian | Jan 2008 | A1 |
20080294164 | Frank | Nov 2008 | A1 |
20100152740 | O'Reilly et al. | Jun 2010 | A1 |
20100179551 | Keller et al. | Jul 2010 | A1 |
20120143192 | Watanabe et al. | Jun 2012 | A1 |
20120221005 | Corneille et al. | Aug 2012 | A1 |
20140052132 | Matityahu et al. | Feb 2014 | A1 |
20140330274 | Matityahu et al. | Nov 2014 | A1 |
20140378973 | Mueckter | Dec 2014 | A1 |
20150112345 | Boraiah | Apr 2015 | A1 |
20150182266 | Jakob et al. | Jul 2015 | A1 |
20150265323 | Sems et al. | Sep 2015 | A1 |
20160166264 | Ritchey et al. | Jun 2016 | A1 |
20160256202 | Halder | Sep 2016 | A1 |
20190038326 | Hedgeland et al. | Feb 2019 | A1 |
20200113609 | Aneja et al. | Apr 2020 | A1 |
20210015526 | Oberli et al. | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
199205200 | Oct 1992 | DE |
20002988 | Jun 2000 | DE |
102007016459 | Oct 2008 | DE |
355411 | Feb 1990 | EP |
1199995 | Sep 2007 | EP |
1654993 | Jan 2008 | EP |
1053718 | Jul 2008 | EP |
1974681 | Jun 2010 | EP |
1495733 | Sep 2010 | EP |
1859751 | Sep 2010 | EP |
1867294 | Sep 2010 | EP |
2109404 | Jan 2012 | EP |
1948049 | May 2012 | EP |
2341854 | Sep 2013 | EP |
2349040 | Aug 2014 | EP |
2712562 | Jul 2015 | EP |
2672909 | Oct 2015 | EP |
2783649 | May 2016 | EP |
2755580 | Jun 2016 | EP |
2672910 | Jul 2016 | EP |
2445346 | Mar 2011 | GB |
2000-342596 | Dec 2000 | JP |
2000076414 | Dec 2000 | WO |
2007048038 | Apr 2007 | WO |
2008094407 | Aug 2008 | WO |
2010014694 | Feb 2010 | WO |
2010043380 | Apr 2010 | WO |
2012107056 | Aug 2012 | WO |
2012107226 | Aug 2012 | WO |
2013037386 | Mar 2013 | WO |
2015106319 | Jul 2015 | WO |
2016042148 | Mar 2016 | WO |
2016131094 | Aug 2016 | WO |
2016151611 | Sep 2016 | WO |
2017121772 | Jul 2017 | WO |
2018172974 | Sep 2018 | WO |
Number | Date | Country | |
---|---|---|---|
20230338066 A1 | Oct 2023 | US |